Novo A/S Insider Trading
Get the latest insider transactions of Novo A/S. Novo A/S is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY). Discover the current value of Novo A/S shares.
Address: KROGSHOJVEJ 41 BAGSVAERD DK-2800Denmark
Novo A/S is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
BMTI | BIOMIMETIC THERAPEUTICS, INC. | 10% Owner | 2,371,771 | 0.00 |
OPHT | IVERIC bio, Inc. | 10% Owner | 1,405,487 | 6,226,307.41 |
TBRA | Tobira Therapeutics, Inc. | 10% Owner | 1,914,541 | 80,583,030.69 |
CLCD | CoLucid Pharmaceuticals, Inc. | 10% Owner | 3,156,563 | 146,464,523.20 |
HTGM | HTG MOLECULAR DIAGNOSTICS, INC | 10% Owner | 1,102,651 | 2,028,877.84 |
FLXN | Flexion Therapeutics Inc | 10% Owner | 2,133,131 | 40,614,814.24 |
CRVS | Corvus Pharmaceuticals, Inc. | 10% Owner | 2,130,938 | 29,470,872.54 |
RETA | REATA PHARMACEUTICALS INC | 10% Owner | 642,405 | 14,794,587.15 |
IRTC | iRhythm Technologies, Inc. | 10% Owner | 2,024,448 | 69,843,456.00 |
RARX | Ra Pharmaceuticals, Inc. | 10% Owner | 924,970 | 16,806,704.90 |
ANAB | ANAPTYSBIO, INC | 10% Owner | 1,936,604 | 35,904,638.16 |
LPTN | Apollo Endosurgery, Inc. | 10% Owner | 1,334,772 | 3,910,881.96 |
KALV | KalVista Pharmaceuticals, Inc. | 10% Owner | 2,311,927 | 1,572,110.36 |
ETTX | Entasis Therapeutics Holdings Inc. | 10% Owner | 1,092,008 | |
MIST | Milestone Pharmaceuticals Inc. | 10% Owner | 2,434,470 | |
MORF | Morphic Holding, Inc. | 10% Owner | 1,978,779 | |
MIRM | Mirum Pharmaceuticals, Inc. | 10% Owner | 1,870,147 | |
GRTX | Galera Therapeutics, Inc. | 10% Owner | 2,459,021 | |
NKTX | Nkarta, Inc. | 10% Owner | 2,238,310 | |
INZY | Inozyme Pharma, Inc. | 10% Owner | 2,194,379 | |
CMPI | Checkmate Pharmaceuticals, Inc. | 10% Owner | 1,670,100 | |
HRMY | Harmony Biosciences Holdings, Inc. | 10% Owner | 4,277,300 | |
SPRB | SPRUCE BIOSCIENCES, INC. | 10% Owner | 4,739,336 | |
PRAX | Praxis Precision Medicines, Inc. | 10% Owner | 2,442,080 | |
ALGS | Aligos Therapeutics, Inc. | 10% Owner | 2,414,563 | |
EAR | Eargo, Inc. | 10% Owner | 737,071 | |
BOLT | Bolt Biotherapeutics, Inc. | 10% Owner | 4,103,991 | |
INGN | Inogen Inc | 10% Owner | 2,759,320 | 183,246,441.20 |
EWTX | Edgewise Therapeutics, Inc. | 10% Owner | 4,962,207 | |
RPHM | Reneo Pharmaceuticals, Inc. | 10% Owner | 2,763,711 |
Insider Trading Transactions of Novo A/S
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | RPHM | Reneo Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,763,711 | 0 | 2,763,711 |
Apr 14 2021 | RPHM | Reneo Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 666,666 | 9,999,990 | 3,430,377 |
Apr 14 2021 | RPHM | Reneo Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 12,367,054 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 4,962,207 | 0 | 4,962,207 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | Novo Holdings A/S | 10% Owner | Buy | 16.00 | 625,000 | 10,000,000 | 5,587,207 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 2,359,440 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,952,439 | 0 | 0 |
Mar 31 2021 | EWTX | Edgewise Therapeutics, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 650,328 | 0 | 0 |
Mar 03 2021 | INGN | Inogen Inc | Novo Holdings A/S | 10% Owner | Sell | 49.00 | 790,000 | 38,710,000 | 2,759,320 |
Feb 19 2021 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Sell | 10.58 | 500,000 | 5,290,000 | 2,459,021 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 4,027,088 | 0 | 4,103,991 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Buy | 20.00 | 400,000 | 8,000,000 | 4,503,991 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,096,323 | 0 | 0 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 2,050,758 | 0 | 0 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 421,670 | 0 | 0 |
Feb 11 2021 | BOLT | Bolt Biotherapeutics, Inc ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 458,337 | 0 | 0 |
Oct 22 2020 | ALGS | Aligos Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,414,563 | 0 | 2,414,563 |
Oct 22 2020 | ALGS | Aligos Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 200,000 | 3,000,000 | 2,614,563 |
Oct 22 2020 | ALGS | Aligos Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,609,493 | 0 | 0 |
Oct 22 2020 | ALGS | Aligos Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 563,851 | 0 | 0 |
Oct 22 2020 | ALGS | Aligos Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 241,219 | 0 | 0 |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 737,071 | 0 | 737,071 |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Buy | 18.00 | 150,000 | 2,700,000 | 887,071 |
Oct 22 2020 | EAR | Eargo, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 737,071 | 0 | 0 |
Oct 21 2020 | PRAX | Praxis Precision Medicine ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,442,080 | 0 | 2,442,080 |
Oct 21 2020 | PRAX | Praxis Precision Medicine ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 4,150,000 | 0 | 0 |
Oct 21 2020 | PRAX | Praxis Precision Medicine ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 551,794 | 0 | 0 |
Oct 21 2020 | PRAX | Praxis Precision Medicine ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 171,410 | 0 | 0 |
Oct 21 2020 | PRAX | Praxis Precision Medicine ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 352,734 | 0 | 0 |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 4,739,336 | 0 | 4,739,336 |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 250,000 | 3,750,000 | 4,989,336 |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 21,000,000 | 0 | 0 |
Oct 16 2020 | SPRB | SPRUCE BIOSCIENCES, INC. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 10,000,000 | 0 | 0 |
Aug 25 2020 | HRMY | Harmony Biosciences Holdi ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 4,277,300 | 0 | 4,277,300 |
Aug 25 2020 | HRMY | Harmony Biosciences Holdi ... | Novo Holdings A/S | 10% Owner | Buy | 24.00 | 132,503 | 3,180,072 | 4,409,803 |
Aug 25 2020 | HRMY | Harmony Biosciences Holdi ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 25,000,000 | 0 | 0 |
Aug 25 2020 | HRMY | Harmony Biosciences Holdi ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,860,107 | 0 | 0 |
Aug 13 2020 | CMPI | Checkmate Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 1,670,100 | 0 | 1,670,100 |
Aug 13 2020 | CMPI | Checkmate Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 500,000 | 7,500,000 | 2,170,100 |
Aug 13 2020 | CMPI | Checkmate Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 12,487,512 | 0 | 0 |
Jul 29 2020 | INZY | Inozyme Pharma, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,194,379 | 0 | 2,194,379 |
Jul 29 2020 | INZY | Inozyme Pharma, Inc. | Novo Holdings A/S | 10% Owner | Buy | 16.00 | 375,000 | 6,000,000 | 2,569,379 |
Jul 29 2020 | INZY | Inozyme Pharma, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 15,000,000 | 0 | 0 |
Jul 29 2020 | INZY | Inozyme Pharma, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,398,600 | 0 | 0 |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,238,310 | 0 | 2,238,310 |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Buy | 18.00 | 555,555 | 9,999,990 | 2,793,865 |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 525,499 | 0 | 0 |
Jul 16 2020 | NKTX | Nkarta, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,712,811 | 0 | 0 |
Jul 09 2020 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Sell | 5.25 | 796,622 | 4,183,381 | 2,130,938 |
Jul 09 2020 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Sell | 5.37 | 741,440 | 3,985,166 | 1,389,498 |
Nov 27 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Sell | 16.00 | 240,000 | 3,840,000 | 2,434,470 |
Nov 14 2019 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 2,373,152 | 0 | 2,373,152 |
Nov 14 2019 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 535,869 | 0 | 2,909,021 |
Nov 14 2019 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Buy | 12.00 | 500,000 | 6,000,000 | 3,409,021 |
Nov 14 2019 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 12,000,000 | 0 | 0 |
Nov 14 2019 | GRTX | Galera Therapeutics, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 2,709,659 | 0 | 0 |
Jul 25 2019 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Sell | 5.32 | 39,716 | 211,134 | 4,380,800 |
Jul 25 2019 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Sell | 5.01 | 53,240 | 266,711 | 4,327,560 |
Jul 25 2019 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Sell | 4.00 | 1,400,000 | 5,600,000 | 2,927,560 |
Jul 23 2019 | MIRM | Mirum Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 1,870,147 | 0 | 1,870,147 |
Jul 23 2019 | MIRM | Mirum Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 575,000 | 8,625,000 | 2,445,147 |
Jul 23 2019 | MIRM | Mirum Pharmaceuticals, In ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,870,147 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 1,978,779 | 0 | 1,978,779 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 666,667 | 10,000,005 | 2,645,446 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,978,779 | 0 | 0 |
May 14 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 1,377,048 | 0 | 1,377,048 |
May 14 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 964,089 | 0 | 2,341,137 |
May 14 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 333,333 | 4,999,995 | 2,674,470 |
May 14 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,377,048 | 0 | 0 |
May 14 2019 | MIST | Milestone Pharmaceuticals ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 964,089 | 0 | 0 |
Oct 01 2018 | ETTX | Entasis Therapeutics Hold ... | Novo Holdings A/S | 10% Owner | Buy | 0.00 | 1,092,008 | 0 | 1,092,008 |
Oct 01 2018 | ETTX | Entasis Therapeutics Hold ... | Novo Holdings A/S | 10% Owner | Buy | 15.00 | 1,089,835 | 16,347,525 | 2,181,843 |
Oct 01 2018 | ETTX | Entasis Therapeutics Hold ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 7,000,000 | 0 | 0 |
Oct 01 2018 | ETTX | Entasis Therapeutics Hold ... | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 14,237,288 | 0 | 0 |
Mar 13 2018 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Buy | 8.50 | 1,176,470 | 9,999,995 | 4,420,516 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 10.36 | 413,356 | 4,281,004 | 2,311,927 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 11.18 | 190,981 | 2,134,404 | 2,120,946 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 12.32 | 165,199 | 2,036,012 | 1,955,747 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 13.39 | 61,044 | 817,330 | 1,894,703 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 14.07 | 57,580 | 809,961 | 1,837,123 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 15.36 | 75,123 | 1,153,889 | 1,762,000 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 10.21 | 35,519 | 362,763 | 1,726,481 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 10.02 | 481 | 4,820 | 1,726,000 |
Oct 12 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 8.50 | 1,726,000 | 14,671,000 | 0 |
Sep 15 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 8.02 | 25,900 | 207,614 | 2,876,027 |
Sep 15 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 8.05 | 10,000 | 80,500 | 2,866,027 |
Sep 15 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 7.00 | 140,744 | 985,841 | 2,725,283 |
Sep 15 2017 | KALV | KalVista Pharmaceuticals, ... | Novo Holdings A/S | 10% Owner | Sell | 8.00 | 3 | 24 | 2,725,280 |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 2.02 | 47,162 | 95,475 | 1,102,651 |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 1.91 | 382,437 | 729,919 | 720,214 |
Aug 25 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 1.75 | 720,214 | 1,260,591 | 0 |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 2.10 | 55,100 | 115,600 | 1,225,085 |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 2.02 | 12,845 | 25,976 | 1,212,240 |
Aug 22 2017 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo Holdings A/S | 10% Owner | Sell | 2.01 | 12,641 | 25,412 | 1,199,599 |
Aug 21 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 21.10 | 356,300 | 7,518,251 | 1,936,604 |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 21.79 | 35,172 | 766,493 | 2,436,332 |
Aug 16 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 21.00 | 143,428 | 3,011,988 | 2,292,904 |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 22.00 | 10,271 | 225,963 | 2,952,527 |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 21.10 | 480,000 | 10,128,000 | 2,472,527 |
Aug 08 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 22.92 | 1,023 | 23,443 | 2,471,504 |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 23.87 | 23,555 | 562,270 | 3,009,949 |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 23.87 | 25,700 | 613,485 | 2,984,249 |
Aug 03 2017 | ANAB | ANAPTYSBIO INC | Novo Holdings A/S | 10% Owner | Sell | 22.01 | 21,451 | 472,192 | 2,962,798 |
Jul 26 2017 | LPTN | Apollo Endosurgery, Inc. | Novo Holdings A/S | 10% Owner | Sell | 6.83 | 17,200 | 117,538 | 1,334,772 |
Jul 26 2017 | LPTN | Apollo Endosurgery, Inc. | Novo Holdings A/S | 10% Owner | Sell | 6.96 | 24,504 | 170,585 | 1,310,268 |
Jul 26 2017 | LPTN | Apollo Endosurgery, Inc. | Novo Holdings A/S | 10% Owner | Sell | 6.84 | 8,426 | 57,643 | 1,301,842 |
Jun 27 2017 | CRVS | Corvus Pharmaceuticals, I ... | Novo Holdings A/S | 10% Owner | Buy | 10.95 | 20,000 | 219,000 | 3,244,046 |
Jun 23 2017 | RETA | REATA PHARMACEUTICALS INC | Novo Holdings A/S | 10% Owner | Option Exercise | 0.00 | 1,200,000 | 0 | 1,201,969 |
Jun 14 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 25.47 | 11,389 | 290,073 | 642,405 |
Jun 14 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 25.03 | 49,611 | 1,241,853 | 592,794 |
Jun 12 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 26.00 | 130,000 | 3,380,000 | 746,297 |
Jun 12 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 25.89 | 2,200 | 56,955 | 744,097 |
Jun 12 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 25.28 | 90,303 | 2,282,824 | 653,794 |
Jun 07 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 28.67 | 23,327 | 668,825 | 942,467 |
Jun 07 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 28.09 | 64,170 | 1,802,490 | 878,297 |
Jun 07 2017 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Sell | 28.04 | 2,000 | 56,079 | 876,297 |
May 11 2017 | LPTN | Apollo Endosurgery, Inc. | Novo A/S | 10% Owner | Sell | 5.74 | 1,500 | 8,609 | 1,455,472 |
May 11 2017 | LPTN | Apollo Endosurgery, Inc. | Novo A/S | 10% Owner | Sell | 5.62 | 103,500 | 582,094 | 1,351,972 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 0.00 | 1,428,571 | 0 | 1,428,571 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 0.00 | 486,820 | 0 | 1,915,391 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 0.00 | 312,986 | 0 | 2,228,377 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 0.00 | 673,454 | 0 | 2,901,831 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 0.00 | 81,673 | 0 | 2,983,504 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Buy | 15.00 | 50,000 | 750,000 | 3,033,504 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | 0.00 | 1,428,571 | 0 | 0 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | 0.00 | 486,820 | 0 | 0 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | 0.00 | 312,986 | 0 | 0 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | 0.00 | 673,454 | 0 | 0 |
Feb 01 2017 | ANAB | ANAPTYSBIO INC | Novo A/S | 10% Owner | Option Exercise | 4.55 | 117,235 | 533,419 | 0 |
Dec 16 2016 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | 4.97 | 2,205,000 | 10,962,378 | 1,405,487 |
Dec 16 2016 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | 4.72 | 1,405,487 | 6,636,007 | 0 |
Nov 02 2016 | RARX | Ra Pharmaceuticals, Inc. | Novo A/S | 10% Owner | Buy | 0.00 | 924,970 | 0 | 924,970 |
Nov 02 2016 | RARX | Ra Pharmaceuticals, Inc. | Novo A/S | 10% Owner | Buy | 0.00 | 860,438 | 0 | 1,785,408 |
Nov 02 2016 | RARX | Ra Pharmaceuticals, Inc. | Novo A/S | 10% Owner | Buy | 13.00 | 246,154 | 3,200,002 | 2,031,562 |
Nov 02 2016 | RARX | Ra Pharmaceuticals, Inc. | Novo A/S | 10% Owner | Option Exercise | 0.00 | 924,970 | 0 | 0 |
Nov 02 2016 | RARX | Ra Pharmaceuticals, Inc. | Novo A/S | 10% Owner | Option Exercise | 0.00 | 860,438 | 0 | 0 |
Oct 26 2016 | IRTC | iRhythm Technologies, Inc ... | Novo A/S | 10% Owner | Buy | 0.00 | 2,007,449 | 0 | 2,024,448 |
Oct 26 2016 | IRTC | iRhythm Technologies, Inc ... | Novo A/S | 10% Owner | Buy | 17.00 | 100,000 | 1,700,000 | 2,124,448 |
Oct 26 2016 | IRTC | iRhythm Technologies, Inc ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 2,007,449 | 0 | 0 |
Sep 13 2016 | CLCD | CoLucid Pharmaceuticals, ... | Novo A/S | 10% Owner | Buy | 20.00 | 100,000 | 2,000,000 | 3,156,563 |
Jul 13 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.19 | 20,431 | 249,101 | 1,914,541 |
Jul 13 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.12 | 8,752 | 106,072 | 1,905,789 |
Jul 13 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 11.88 | 29,884 | 354,944 | 1,875,905 |
Jul 07 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.57 | 10,400 | 130,709 | 2,016,691 |
Jul 07 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.20 | 59,850 | 730,272 | 1,956,841 |
Jul 07 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.03 | 21,869 | 263,150 | 1,934,972 |
Jun 30 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 13.77 | 20,883 | 287,651 | 2,073,022 |
Jun 30 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 14.28 | 2,730 | 38,975 | 2,070,292 |
Jun 30 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.63 | 16,068 | 202,947 | 2,054,224 |
Jun 30 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 12.58 | 27,133 | 341,368 | 2,027,091 |
Jun 07 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 10.37 | 187,500 | 1,943,906 | 2,093,905 |
Jun 02 2016 | RETA | REATA PHARMACEUTICALS INC | Novo A/S | 10% Owner | Buy | 11.00 | 750,000 | 8,250,000 | 750,000 |
May 25 2016 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | 49.00 | 1,300,000 | 63,700,000 | 3,610,489 |
May 16 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Buy | 10.00 | 70,000 | 700,000 | 3,224,046 |
Mar 30 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Buy | 0.00 | 2,130,492 | 0 | 2,130,492 |
Mar 30 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Buy | 0.00 | 356,888 | 0 | 2,487,380 |
Mar 30 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Buy | 15.00 | 666,666 | 9,999,990 | 3,154,046 |
Mar 30 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 2,130,492 | 0 | 0 |
Mar 30 2016 | CRVS | Corvus Pharmaceuticals, I ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 356,888 | 0 | 0 |
Mar 04 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 6.92 | 110,000 | 761,024 | 2,361,405 |
Mar 04 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 6.86 | 25,000 | 171,395 | 2,336,405 |
Mar 04 2016 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 6.54 | 55,000 | 359,667 | 2,281,405 |
Nov 19 2015 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 9.87 | 71,399 | 704,394 | 2,625,006 |
Nov 19 2015 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Sell | 9.76 | 153,601 | 1,498,685 | 2,471,405 |
Jun 22 2015 | FLXN | Flexion Therapeutics Inc | Novo A/S | 10% Owner | Sell | 21.51 | 35,700 | 767,903 | 2,247,431 |
Jun 22 2015 | FLXN | Flexion Therapeutics Inc | Novo A/S | 10% Owner | Sell | 20.07 | 50,888 | 1,021,225 | 2,196,543 |
Jun 22 2015 | FLXN | Flexion Therapeutics Inc | Novo A/S | 10% Owner | Sell | 20.55 | 63,412 | 1,302,844 | 2,133,131 |
May 12 2015 | CLCD | CoLucid Pharmaceuticals, ... | Novo A/S | 10% Owner | Buy | 0.00 | 1,756,563 | 0 | 1,756,563 |
May 12 2015 | CLCD | CoLucid Pharmaceuticals, ... | Novo A/S | 10% Owner | Buy | 10.00 | 1,300,000 | 13,000,000 | 3,056,563 |
May 12 2015 | CLCD | CoLucid Pharmaceuticals, ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 1,756,563 | 0 | 0 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Buy | 0.00 | 754,538 | 0 | 754,538 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Buy | 0.00 | 110,755 | 0 | 865,293 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Buy | 0.00 | 49,786 | 0 | 915,079 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Buy | 14.00 | 365,106 | 5,111,484 | 1,280,185 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 598,415 | 0 | 0 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 156,123 | 0 | 0 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 110,755 | 0 | 0 |
May 12 2015 | HTGM | HTG MOLECULAR DIAGNOSTICS ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 49,786 | 0 | 0 |
May 06 2015 | TBRA | Tobira Therapeutics, Inc. | Novo A/S | 10% Owner | Buy | 10.62 | 838,041 | 8,899,995 | 2,696,405 |
Mar 26 2015 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Buy | 0.06 | 13,668 | 806 | 4,910,487 |
Mar 26 2015 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Option Exercise | 0.06 | 13,668 | 806 | 0 |
Mar 09 2015 | OPHT | Ophthotech Corp. | Novo A/S | 10% Owner | Sell | 51.75 | 1,005,000 | 52,008,750 | 4,896,819 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Buy | 0.00 | 758,097 | 0 | 758,097 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Buy | 0.00 | 196,351 | 0 | 954,448 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Buy | 0.00 | 738,174 | 0 | 1,692,622 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Buy | 0.00 | 343,574 | 0 | 2,036,196 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Buy | 12.46 | 335,575 | 4,180,459 | 2,371,771 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 758,097 | 0 | 0 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 196,351 | 0 | 0 |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPEUTICS, ... | Novo A/S | 10% Owner | Option Exercise | 0.00 | 738,174 | 0 | 0 |